DONATE

The University of Calgary joins the BPDCN International Registry

The University of Calgary is a public research university located in Calgary, Alberta, Canada. It was founded in 1966 and has since grown to become one of Canada's leading universities, with a reputation for excellence in teaching, research, and community engagement.

The University is committed to research and innovation, and is home to several research institutes and centres. 


About the BPDCN International Registry

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy discovered in 2008. The International Registry is a multicenter, international prospective and retrospective registry with the aim of collecting data of patients with a diagnosis of BPDCN globally. If you think your hospital would benefit from partnership in this registry, please contact Dr.Astghik Voskanyan ([email protected]). 


About IMMONC

Immune Oncology Research Institute (IMMONC) is dedicated to advancing research aimed at preventing, treating, and ultimately curing cancer while making these innovations accessible to those who need them. If you're interested in joining our team, please feel free to contact us at [email protected] or at +374-41 310-048.